文献速递细菌感染、耐药与抗菌药物医院感染防控

口腔微生物组改变与累积碳青霉烯暴露与急性髓系白血病化疗患者嗜麦芽窄食单胞菌感染相关

Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving Chemotherapy.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究为前瞻性观察性队列的子分析,纳入90例接受缓解诱导化疗的急性髓系白血病患者,评估口腔和粪便微生物组及累积抗生素使用对嗜麦芽窄食单胞菌感染的预测作用。

要点

  • 口腔嗜麦芽窄食单胞菌相对丰度36%可预测感染,灵敏度96%,特异度93%。
  • 粪便微生物组相对丰度与嗜麦芽窄食单胞菌感染无关联。

核心结论

  • 口腔微生物组是嗜麦芽窄食单胞菌感染的潜在来源。
  • 累积碳青霉烯使用是白血病患者嗜麦芽窄食单胞菌感染的危险因素。
  • 实时口腔监测可能识别感染高危患者。

研究设计与样本

  • 前瞻性观察性队列的子分析,纳入2013年9月至2015年8月接受缓解诱导化疗的急性髓系白血病患者90例。
  • 采集从缓解诱导化疗开始至中性粒细胞恢复期间的口腔和粪便样本,通过16S rRNA基因定量评估嗜麦芽窄食单胞菌相对丰度。
  • 主要结局为微生物学证实的嗜麦芽窄食单胞菌感染,采用时变Cox比例风险模型分析。

主要发现

  • 90例患者中8例(9%)发生嗜麦芽窄食单胞菌感染,其中肺炎6例,皮肤软组织感染2例。
  • 口腔嗜麦芽窄食单胞菌相对丰度36%预测感染,灵敏度96%,特异度93%。
  • 粪便相对丰度与嗜麦芽窄食单胞菌感染无关联。

关键数值与推荐

  • 口腔嗜麦芽窄食单胞菌相对丰度阈值36%用于预测感染,灵敏度96%,特异度93%。

临床怎么用

  • 对接受缓解诱导化疗的急性髓系白血病患者,可考虑实时监测口腔微生物组以识别嗜麦芽窄食单胞菌感染高危患者。
  • 临床应关注累积碳青霉烯暴露,权衡使用以避免增加嗜麦芽窄食单胞菌感染风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stenotrophomonas maltophilia is increasingly common in patients with acute myeloid leukemia (AML). Little is known about factors that drive S. maltophilia infection. We evaluated the microbiome and cumulative antibiotic use as predictors of S. maltophilia infection in AML patients receiving remission induction chemotherapy (RIC). METHODS: Subanalysis of a prospective, observational cohort of patients with AML receiving RIC between September 2013 and August 2015 was performed. Fecal and oral microbiome samples collected from initiation of RIC until neutrophil recovery were assessed for the relative abundance of Stenotrophomonas via 16S rRNA gene quantitation. The primary outcome, microbiologically proven S. maltophilia infection, was analyzed using a time-varying Cox proportional hazards model. RESULTS: Of 90 included patients, 8 (9%) developed S. maltophilia infection (pneumonia, n = 6; skin-soft tissue, n = 2); 4/8 (50%) patients were bacteremic; and 7/8 (88%) patients with S. maltophilia infection had detectable levels of Stenotrophomonas vs 22/82 (27%) without infection (P < .01). An oral Stenotrophomonas relative abundance of 36% predicted infection (sensitivity, 96%; specificity, 93%). No association of S. maltophilia infection with fecal relative abundance was found. Cumulative meropenem exposure was associated with increased infection risk (hazard ratio, 1.17; 95% confidence interval, 1.01-1.35; P = .03). CONCLUSIONS: Here, we identify the oral microbiome as a potential source for S. maltophilia infection and highlight cumulative carbapenem use as a risk factor for S. maltophilia in leukemia patients. These data suggest that real-time monitoring of the oral cavity might identify patients at risk for S. maltophilia infection.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Aitken SL, Sahasrabhojane PV, Kontoyiannis DP, et al. Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving Chemotherapy. Clin Infect Dis. 2021. PMID: 32544947. doi:10.1093/cid/ciaa778

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。